Blog

American Association for Cancer Research Conference on Optimizing Therapeutic Efficacy and Tolerability through Cancer Chemistry

www.aacr.org

Oct 28, 2024, 09:45

American Association for Cancer Research Conference on Optimizing Therapeutic Efficacy and Tolerability through Cancer Chemistry

American Association for Cancer Research shared a post on LinkedIn:

“Register by October 28 to get the lowest rates for the AACR Conference on Optimizing Therapeutic Efficacy and Tolerability through Cancer Chemistry (December 9-11, Toronto), chaired by Philip Jones, Angela N. Koehler, and Chudi Ndubaku and organized in association with the AACR Chemistry in Cancer Research Working Group.

Learn more.”

AACR AACR Conference American Association for Cancer Research Angela N. Koehler cancer cancer awareness cancer care Chudi Ndubaku fight against cancer Global fight against cancer OncoDaily Oncology Philip Jones

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage